Mirum Pharmaceuticals (MIRM) Earnings Date & Reports
A.I. Advisor
published Earnings
MIRM is expected to report earnings to fall 27.23% to -37 cents per share on November 06
Q3'24
Est.
$-0.38
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.12
Q4'23
Beat
by $0.24
Q3'23
Beat
by $0.06
The last earnings report on August 07 showed earnings per share of -51 cents, missing the estimate of -46 cents. With 295.35K shares outstanding, the current market capitalization sits at 1.99B.
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.